EIS vs. ARKG ETF Comparison

Comparison of iShares MSCI Israel Capped Investable Market Index Fund (EIS) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
EIS

iShares MSCI Israel Capped Investable Market Index Fund

EIS Description

The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Israel Capped Investable Market Index (the "underlying index"). The fund will at all times invest at least 90% of its assets in the securities of the underlying index or in depositary receipts representing securities in its underlying index. The underlying index is a custom, free float-adjusted market capitalization index designed to measure broad-based equity market performance in Israel. The underlying index consists of stocks traded primarily on the Tel Aviv Stock Exchange. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$58.55

Average Daily Volume

44,026

Number of Holdings *

22

* may have additional holdings in another (foreign) market
ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$24.25

Average Daily Volume

2,385,951

Number of Holdings *

38

* may have additional holdings in another (foreign) market
Performance
Period EIS ARKG
30 Days -3.38% -12.45%
60 Days -4.55% -21.89%
90 Days 4.60% -16.50%
12 Months 11.50% -17.85%
0 Overlapping Holdings
Symbol Grade Weight in EIS Weight in ARKG Overlap
EIS Overweight 22 Positions Relative to ARKG
Symbol Grade Weight
TEVA C 8.15%
CHKP C 7.85%
CYBR D 5.49%
WIX D 3.75%
MNDY D 3.21%
GLBE F 1.7%
INMD F 0.79%
ODD F 0.59%
ZIM F 0.55%
KRNT F 0.42%
RDWR F 0.34%
FVRR F 0.33%
NNDM F 0.31%
CLBT D 0.29%
RSKD B 0.25%
SMMF D 0.25%
ITRN D 0.21%
NGMS A 0.2%
TARO D 0.2%
PGY F 0.19%
SMWB C 0.12%
WKME F 0.09%
EIS Underweight 38 Positions Relative to ARKG
Symbol Grade Weight
CRSP D -7.23%
TWST D -6.08%
EXAS C -5.67%
RXRX F -5.36%
SDGR F -4.55%
NTLA F -3.97%
TXG F -3.92%
IONS F -3.92%
BEAM F -3.87%
DNA F -3.67%
ARCT D -3.65%
CDNA F -3.54%
TDOC F -3.22%
ACCD F -3.21%
NRIX A -2.99%
MRNA B -2.76%
VCYT F -2.69%
PACB F -2.63%
VEEV D -2.61%
VRTX D -2.38%
ADPT F -1.83%
MASS F -1.72%
VERV F -1.61%
QSI D -1.53%
INCY F -1.49%
ABSI A -1.32%
CMPS D -1.31%
PATH D -1.19%
PRME F -1.17%
REGN D -1.1%
AMGN D -0.92%
CERS F -0.92%
RPTX F -0.7%
BFLY F -0.7%
PSNL F -0.57%
NTRA B -0.53%
GH F -0.44%
NVDA A -0.22%
Compare ETFs